Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 4: Study of Ketamine Inhibition of Interleukin 6 in Hepatic Resections Requiring Temporary Porto-arterial Occlusion

NCT00978757 is registered in ClinicalTrials.gov with Hospital Italiano de Buenos Aires as lead sponsor.

NCT NCT00978757
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00978757 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 4: Study of Ketamine Inhibition of Interleukin 6 in Hepatic Resections Requiring Temporary Porto-arterial Occlusion
Lead sponsor
Hospital Italiano de Buenos Aires
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2001
Completion date
June 30, 2008
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatectomy